BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Stay ahead in an era where advanced therapies are transforming medicine-and redefining how innovation must be protected. The IP and Pat ent Strategy for Advanced Therapies Summit 2025 is the only event dedicat ed to shaping holistic\, forward-looking IP strategies exclusively for ce ll\, gene\, and next-generation treatments.\n\nAs more complex therapies move through development pipelines\, traditional patent approaches fall s hort. This summit goes beyond technical tactics to tackle strategic decis ions across the full patent life cycle\, with a special emphasis on early -stage patentability\, freedom to operate\, and the use of AI-driven tool s to uncover opportunity.\n\nAgainst a backdrop of rapidly evolving regul ations\, patent cliffs\, and landmark legal battles\, now is the moment t o rethink how you safeguard commercial potential and secure market advant age. Join top IP leaders to benchmark your approach and build the resilie nt strategy these therapies demand.\n\n \;\n\nURLs:Tickets: \;htt ps://go.evvnt.com/3157041-1?pid=185 \;Brochure: \;https://go.evvn t.com/3157041-2?pid=185 \;\n\nDate and Time: Tue\, 28 Oct 2025 08:00 - Wed\, 29 Oct 2025 16:00\n\nVenue details: Wyndham Boston Beacon Hill\, 5 Blossom Street\, Boston\, Massachusetts\, 02114\, United States\n\nCate gory: Conferences | Science\, Health &\; Medicine | Pharmaceuticals | Regulatory Affairs\n\nPrices:Drug Developer - 2-Day Conference Pass: USD 2999.00\,Academic and Researcher - 2-Day Conference Pass: USD 2599.00\,La w Firm and Solution Provider - 2-Day Conference Pass: USD 3699.00\n\nSpea kers: Dhara Patel\, Assistant General Counsel\, Intellectual Property\, B lueRock Therapeutics\, Jon Aumais\, Formerly Senior Patent Agent\, Genent ech\, Katie Merriman\, Executive Director\, Intellectual Property\, Umoja Biopharma\, Raphaël Ognar\, President\, Chief Executive Officer\, Co-Fou nder and Chairman of the Board\, NKILT Therapeutics\, William Coppola\, E xecutive Director\, Intellectual Property\, Celularity\, Will Rosellini\, President\, CytoImmune Therapeutics\, Adam Gastonguay\, Director\, Paten t Counsel\, Regeneron\, Marthe Lindenbergh\, Director\, Intellectual Prop erty\, uniQure\, Christina Jordan\, Senior Director\, Intellectual Proper ty\, Tune Therapeutics\, Elbert Chiang\, Vice President\, Intellectual Pr operty\, Beam Therapeutics\, Jeanne Wilson\, Director\, Intellectual Prop erty\, Intellia Therapeutics\, TJ Cradick\, Chief Scientific Officer and Principal\, Gene Editing Frontiers\, Jacob Sherkow\, Professor of Law and Medicine\, University of Illinois\, David Diamond\, Vice President and H ead of Intellectual Property\, Capstan Therapeutics\, Kady Bruce\, Patent Counsel\, BioNTech\, Marshall Byrd\, Senior Director IP Management\, Cur eVac\n DTEND:20251029T160000 DTSTAMP:20260512T220029Z DTSTART:20251028T080000 LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom Street\, Boston\, Massachu setts\, 02114\, SEQUENCE:0 SUMMARY:Stay ahead in an era where advanced therapies are transforming med icine-and redefining how innovation must be protected. The IP and Patent Strategy... UID:06872822-e2bb-4dc9-bb1a-9986151d76c9 END:VEVENT END:VCALENDAR